Skip to main content
. 2026 Jun 16;26:519. doi: 10.1186/s12886-026-04989-1

Table 1.

Comparison of baseline characteristics among four groups

Characteristics Group A1 (n = 15) Group A2 (n = 14) P₁* Group B1 (n = 12) Group B2 (n = 12) P₂*
Gender, No. 0.860 0.105
Male 7 7 5 9
Female 8 7 7 3
Age (years) 55.07 ± 10.21 59.14 ± 12.34 0.340 57.58 ± 9.28 53.58 ± 6.91 0.244
Affected eye, No. 0.579 0.105
Left 8 6 3 7
Right 7 8 9 5
Hypopyon, No. 0.682 0.351
None 11 11 8 5
< 0.5 mm 1 0 0 1
≥ 0.5 mm 3 3 4 6
Disease duration(days) 11.0(10.0,16.0) 28.0(10.3,31.5) 0.105 22.0(10.0,33.0) 29.5(15.0,51.3) 0.154
Systemic diseases, No. 2 1 0.591 0 2 0.148
Previous antifungal therapy, No. 5 3 0.481 4 6 0.408

*P¹, P²: Statistical results comparing baseline characteristics between A1 vs. A2 groups and B1 vs. B2 groups, respectively; categorical variables analyzed using Fisher’s exact test, continuous variables using independent samples t-test or Mann-Whitney U test as appropriate

ᵃIncludes diabetes mellitus, hypertension, and chronic gastritis